prodchem
Jul 29, 2026
Found this useful?
Continue Reading
H.B. Fuller has closed 13 acquisitions since 2023 while simultaneously reducing its net debt-to-adjusted EBITDA ratio to 3.1x from 3.5x a year earlier. Here's how the company is defending its dealmaking pace against activist investor concerns, and what the numbers actually show.
FDA's Human Foods Program guidance agenda is increasingly extending beyond traditional food safety into chemical exposure, ingredient transparency and labeling. For manufacturers, packaging companies and chemical suppliers, the expanding agenda signals a need for stronger coordination between regulatory affairs, procurement, formulation control and supplier documentation.
The Covestro-led bio-based aniline project, backed by $8 million of its $10 million funding from the EU, reflects Europe's broader push to commercialize lower-carbon chemical production. The initiative highlights how public funding is increasingly being used to de-risk technologies that could reduce dependence on fossil feedstocks across major aromatic chemical value chains.
